Abstract
Background conditions in contemporary clinical prediction are unusually favorable for model development and unusually unfavorable for reliable translation. Electronic health records, bedside monitoring systems, imaging archives, laboratory information systems, and registry platforms produce a volume of patient-level information that permits increasingly sophisticated risk estimation. At the same time, care pathways, documentation conventions, intervention timing, and patient selection mechanisms vary substantially across hospitals, regions, and time periods. The result is a persistent mismatch between the apparent success of prediction models in retrospective development settings and their uncertain value when introduced into routine clinical care. This paper argues that generalizability, rather than algorithmic complexity or marginal gains in internal discrimination, constitutes the dominant translational constraint for clinical risk stratification. The analysis treats external validation not as a ceremonial final step but as the principal empirical test of whether a model estimates a quantity that remains meaningful under distributional instability. A formal account of transportability is developed to distinguish statistical prediction from deployable clinical decision support. The paper examines how selection effects, measurement heterogeneity, coding drift, treatment adaptation, missingness mechanisms, and threshold migration alter model behavior outside the development environment. It then outlines a modeling and validation framework centered on multi-domain estimation, calibration across sites, uncertainty quantification, and decision-analytic assessment under plausible forms of dataset shift. The central claim is modest but consequential: many clinically promising models fail to translate not because they are weak predictors in an absolute sense, but because their evidentiary basis remains local while their intended use is nonlocal.